Scandinavian Medical Solutions AS (SMSMED) — Cash Flow Reinvestment Rate
Scandinavian Medical Solutions AS (SMSMED) has a Cash Flow Reinvestment Rate of 0.85x as of September 2024, reinvesting Dkr15.13 Million (capex Dkr15.13 Million ) from operating cash flow of Dkr17.86 Million. Check Scandinavian Medical Solutions AS earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Scandinavian Medical Solutions AS Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Scandinavian Medical Solutions AS across 3 annual periods. Explore Scandinavian Medical Solutions AS (SMSMED) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Scandinavian Medical Solutions AS (2020–2024)
Year-by-year capital reinvestment analysis for Scandinavian Medical Solutions AS. For live market cap and broader valuation context, see Scandinavian Medical Solutions AS (SMSMED) total market value.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 5.53x | Dkr18.77 Million | Dkr3.39 Million | Dkr18.47 Million | ▲ +8193.5% |
| 2021 | 0.07x | Dkr268.50K | Dkr4.02 Million | Dkr5.00 | ▼ -95.5% |
| 2020 | 1.47x | Dkr13.79 Million | Dkr9.38 Million | Dkr13.76 Million | — |